News

Scientists have developed a new test that can help identify people who are likely to develop hepatocellular carcinoma, the most common form of liver cancer. The approach uses a simple blood test to check for the patient’s previous exposure to certain viruses.

The US Food and Drug Administration has approved nivolumab for patients with unresectable advanced, recurrent or metastatic esophageal squamous cell carcinoma (ESCC) after prior fluoropyrimidine- and platinum-based chemotherapy.

A project initially focused on making better fluorescent tags has evolved into a novel method to kill tumors.

A regular dose of aspirin to reduce the risk of inherited bowel cancer lasts at least 10 years after stopping treatment, research has revealed.

A new combination of chemotherapy and immunotherapy shows promise for treating inoperable malignant pleural mesothelioma, according to new research.

A novel mechanism of chemoresistance has been identified, which is driven by the Unfolded Protein Response, a cellular stress response pathway that alters gene expression and cellular metabolism to promote adaption and cell survival upon accumulation of unfolded proteins.

A good vitamin D status is advantageous both in cancer prevention and in the prognosis of several cancers, according to a new research review.

A team of researchers has replicated cancer cells from diseased bladder tissue in dogs, minimizing the use of costly stem cell products.

A research team has developed a method to artificially produce a fungal compound capable of rearming the self-destruct gene in certain cancer cells, providing a potential cancer therapeutic strategy.

Key recommendations, which were published in the Journal of Clinical Oncology, include a strong endorsement to perform genetic testing of all men with metastatic prostate cancer to inform precision medicine or clinical trial eligibility.